glp-1 nobel prize A future Prize? Looking back to the discovery history of drugs such as Semaglutide: it subverted the treatment of diabetes and obesity Tang Prize | Laureates |

Fatigability: A prognostic indicator of phenotypic aging

In Phase 2 trials involving participants with type 2 diabetes, HbA1c improved by up to 2.2%, with 82% of participants reaching HbA1c levels at or below 6.5%

1 , e208e219 (2019)

Are there side effects when combining tirzepatide and lipotropic injections

Endocr Rev 2020;41:bnaa004.PubMedPMC 5

Cost-effectiveness of SGLT2is Under the assumptions of our model, use of SGLT2is was cost-effective: SGLT2i use met the AU$28,000 per QALY willingness-to-pay threshold in most one-way sensitivity and scenario analyses in both populations, and also did so in most probabilistic sensitivity analyses, especially in the secondary prevention population